Effectiveness and Safety of Immune Checkpoint Inhibitors as Second-Line Treatment for Non-Small Cell Lung Cancer: Real-World Study in the Healthcare Area of A Coruña.

Author

Calleja Chucla, Teresa

State

Autorizada defensa

Academic year of defense

2025/2026

Date of defense

11/06/2026, 12:00 h.

Center of defense

Aula 2 CHUAC, 4ª planta

PhD

5007V01 - PhD in Health Sciences

Supervisor(s)

  • Antolín Novoa, Silvia
  • Margusino Framiñán, Luis
  • Pértega Díaz, Sonia

University of A Coruña Repository